Jan 11, 2022 / 02:00PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. Happy to kick off day 2 of the JPMorgan Healthcare Conference on the medtech track. I'm Robbie Marcus, the analyst here for medical devices.
Very happy to have Abbott as our next company. Robert Ford, the CEO, is going to do a little bit of a fireside chat with me. We're going to start off with a couple of questions from my end. And then I can -- feel free to ask questions online or send me, and I could do my best to ask as many as I can.
But Robert, I really appreciate you taking the time to be here and speak today.
Robert B. Ford - Abbott Laboratories - Chairman of the Board, President & CEO
Nice being with you virtually.
Questions and Answers:
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - AnalystYes. So let's start with everybody's favorite discussion, which is COVID testing. Abbott has been a leader here. Maybe give us your latest thoughts and update on the COVID